Dr. Lal Pathlabs Limited — Earnings Release 2025

Apr 25, 2025

==> picture [598 x 65] intentionally omitted <==

April 25, 2025

National Stock Exchange of India Limited BSE Limited Exchange Plaza, Corporate Relationship Department Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Symbol: LALPATHLAB Scrip Code: 539524

Sub: Press Release on Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2025

Dear Sir/ Madam,

Please find enclosed herewith the Press Release on the Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2025.

We request you to please take the same on record.

Thanking You,

Yours Faithfully,

For Dr. Lal PathLabs Limited

Vinay Digitally signed by Vinay Gujral Date: 2025.04.25 14:50:23 +05'30' Gujral Vinay Gujral Company Secretary & Compliance Officer

Encl.: As above

==> picture [588 x 34] intentionally omitted <==

Classification: Internal

For Immediate Release April 25, 2025

==> picture [159 x 37] intentionally omitted <==

Dr Lal PathLabs Limited records revenue of Rs 603 Cr in Q4 FY 2024-25

New Delhi, India, April 25, 2025 – Dr Lal PathLabs Limited (referred to as the “Company”; NSE: LALPATHLAB, BSE: 539524), a leading diagnostic and related healthcare service provider announces their financial results for the quarter ended March 31, 2025.

Consolidated Performance Highlights: Q4 FY25 vs Q4 FY24

• Revenue increased by 10.5% in Q4 FY25

• EBITDA increased by 16.9% with a margin of 28.1%

• PAT increased by 81.4% with a margin for of 25.8%

• Fourth Interim Dividend of Rs. 6 per share for FY25

Financial Overview (Consolidated) in Rs Cr

==> picture [440 x 238] intentionally omitted <==

About Dr Lal PathLabs Limited

Dr Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its’ integrated, nationwide network, the company offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

Dr Lal Pathlabs Limited

1

12[th] Floor, Tower-B, SAS Tower, Sector-38, Medicity, Gurgaon 122001, Phone: +91 124 3016500, website: www.lalpathlabs.com

==> picture [159 x 37] intentionally omitted <==

As on March 31, 2025 the company has 298 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore & Mumbai), 6,607 Patient Service Centers (PSCs) and 12,365 Pick-up Points (PUPs). Its’ customers include individual patients, hospitals and other healthcare providers and corporate customers.

Contact Details

Ved Goel Group Chief Financial Officer Dr Lal PathLabs Limited

Kritika Khatwani Adfactors PR

+91 124 3016500 cfo@lalpathlabs.com +91 8604801332 kritika.khatwani@adfactorspr.com

For further information on Dr Lal PathLabs see www.lalpathlabs.com

Safe Harbour

This release contains statements that contain “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Dr Lal PathLabs future business developments and economic performance. While these forward looking statements indicate our assessment and future expectations concerning the development of our business, a number of risks, uncertainties and other unknown factors could cause actual developments and results to differ materially from our expectations. These factors include, but are not limited to, general market, macro-economic, governmental and regulatory trends, movements in currency exchange and interest rates, competitive pressures, technological developments, changes in the financial conditions of third parties dealing with us, legislative developments, and other key factors that could affect our business and financial performance. Dr Lal PathLabs undertakes no obligation to publicly revise any forward looking statements to reflect future / likely events or circumstances.

Dr Lal Pathlabs Limited

2

12[th] Floor, Tower-B, SAS Tower, Sector-38, Medicity, Gurgaon 122001, Phone: +91 124 3016500, website: www.lalpathlabs.com